Hansen Medical (NSDQ:HNSN) tapped a former Teleflex (NYSE:TFX) executive, Cary Vance, to be its new president & CEO.

Vance was president of Teleflex’s anesthesia & respiratory business, according to the release, and also put in time at Covidien (NYSE:COV) and GE Healthcare (NYSE:GE).

"I am privileged to be joining the company at such an exciting and important stage of its evolution," Vance said in prepared remarks. "Hansen Medical’s intravascular robotics platforms and related products are truly innovative and their potential applications represent a compelling growth opportunity for the company. I look forward to working with the talented group of Hansen Medical employees, leadership team and board of directors, as we continue to demonstrate the breadth of capabilities of our robotic platforms and further validate the clinical and economic benefits of our technologies."

"The board is delighted to welcome Cary as Hansen Medical’s new CEO. Cary has a strong track record in the commercialization of innovative medical devices with capital equipment companies and I am confident that he will lead Hansen towards delivering significant benefits to patients and healthcare providers across the globe," added chairman Michael Eagle.

Hansen, which makes robot-assisted surgery platforms, let former CEO Bruce Barclay go in February after reporting a slide to red ink for the 4th quarter. Vance is slated to take the helm May 23, according to a press release.

"I am thrilled to have Cary join the company. Throughout his career, he has delivered above-average revenue growth while also driving margin expansion opportunities. I am confident that his commercial expertise and leadership will be a tremendous asset for the company," interim CEO Christopher Lowe, a board member since before Hansen’s 2006 IPO, said in the release.